NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Devices · USD

Alphatec Holdings, Inc. (ATEC) Stock Analysis

Alphatec Holdings, Inc. (ATEC) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

ATEC

$9.45

+$0.12 (+1.29%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ATEC with… →

ATEC Key Statistics

As of Sep 4, 2026
Trading
Open
$9.22
Previous Close
$9.33
Day's Range
9.08–9.51
52-Week Range
6.82–23.29
Volume
1.58M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.85
Valuation
Market Cap
$1.46B
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
15.77
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.48
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.79
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.71
Financials (FY)
Revenue (FY)
$764.16M+24.95%
Net Income (FY)
−$143.36M
Profit marginThe share of revenue left as profit after all costs and taxes.
−13.49%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
154.45M
1-Year Return
−42.90%
Dividend and dates
Earnings Date
October 29, 2026
Avg Volume
2.47M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

ATEC Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−55.09%
2025+129.19%
2024−39.25%
2023+22.35%
2022+8.05%
2021−21.28%
2020+104.51%
2019+210.04%
2018−13.91%
2017−17.13%
2016 (partial year)−33.12%

As of September 4, 2026.

ATEC Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$764.16M−$143.36M−18.8%
2024$611.56M−$162.12M−26.5%
2023$482.26M−$186.64M−38.7%
2022$350.87M−$151.29M−43.1%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$764.16M$531.89M−$57.97M−$143.36M−18.8%
2024$611.56M$424.26M−$122.91M−$162.12M−26.5%
2023$482.26M$310.20M−$148.28M−$186.64M−38.7%
2022$350.87M$233.06M−$121.10M−$151.29M−43.1%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

ATEC Valuation vs Medical Devices Median

Median of 151 stocks
MetricATECMedical Devices medianvs median
P/S ratio1.792.9840% below
Profit margin−13.49%−1.69%11.8 pts below

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 11 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Alphatec Holdings, Inc. (ATEC) is capitalised at $1.46B on the latest close. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 913 employees.

The 52-week range on file runs from $6.82 to $23.29. The most recent close on file for ATEC is $9.45, dated September 4, 2026. That is +$0.12 (+1.29%) against the previous close. The latest close sits 38.56% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $764.16M. Against the prior fiscal year total of $611.56M, that is a change of +24.95%. The same year closed with a net loss of $143.36M. Profit margin runs at −13.5%. That is 11.8 percentage points below the Medical Devices median of −1.69%. Trailing earnings per share are −0.71.

Across the 4 fiscal years on file, revenue moves from $350.87M in 2022 to $764.16M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The forward P/E on file is 15.77. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.48. The price-to-sales ratio is 1.79. On price-to-sales that is 39.83% below the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

Over the trailing twelve months the price has returned −42.90%. Measured over 10 years, that is +7.73% a year compounded. Beta against the wider market is reported at 0.85. Annualized volatility over the trailing 10 years is 68.08%.

Growth & Income

The record shows no dividend for ATEC.

The strongest complete calendar year on file is 2019 at +210.04%; the weakest is 2024 at −39.25%. Of the 9 complete calendar years on file, 5 finished higher. 2026 is still running; the price is −55.09% year to date.

Peer Comparison

Alphatec Holdings, Inc. (ATEC) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Alphatec Holdings, Inc. ATEC $1.46B —
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Alphatec Holdings, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Alphatec Holdings, Inc.

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.

Visit website →